Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
about
The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyChemotherapy-induced peripheral neuropathy: Current status and progress.Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature Review.Update on Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic strategies and directions for future research.Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.Discerning the clinical relevance of biomarkers in early stage breast cancer.Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality.Chemotherapy-induced peripheral neuropathy: A current review.Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall riskThe early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review.Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure.Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial.Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathyChemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
P2860
Q28552519-EE697C2D-02F1-4B5F-8A10-4BE71355F4C1Q36421901-309FBDD3-647C-442C-86B3-8B8F1555DFFDQ37662576-40FBE453-4FD8-4D75-90F3-8A78B01999EEQ37696110-BBCC5818-E497-402F-9028-AA4A63405A3DQ38664595-F2EB3F06-B789-4861-8734-31EF29EE54C4Q38700984-FCFDC34A-3D47-442A-9EB6-00F98CFA6B0CQ38726616-71A27E1D-BCC1-4CC6-8FF7-0FB4A2CAE963Q38728572-EB83CBA8-6EB9-4BF3-B1C6-54C934152275Q38769139-6D380AEB-283A-4C56-B318-9B4DFCBA9D99Q38817753-C8E79FC8-8789-46F6-B45B-A01BFEEF4D9BQ38841237-DCD65D92-1738-4325-8904-61156D8B0BECQ39138091-B23CB180-D729-4B18-9099-C484F64DF03FQ39262358-D33BFE39-9251-42EF-B224-F94A86FEEDD8Q39293928-02965F50-A46C-42C5-B091-EE8F3CDDC32AQ39668102-ACE6811E-8A5E-4152-A524-4BDBA2FB66EEQ39796533-BB11E65E-3883-4D29-9C21-9A166223EB92Q41009010-2CBE01F5-218C-4E05-ACEE-D2CCD7AEE179Q41227394-FC2DB75E-4D75-4E25-9A5F-B4DD6888463DQ45971033-FC2900A5-2C29-4C5F-84F5-1BCA51008A13Q46169842-938656CA-494B-4ABF-B572-79908AAB20CFQ46606896-51F014B7-9CCB-470F-B6F8-46EADC3A48A2Q47248078-016AE30A-3582-4942-99BB-077BE24FE587Q47558946-F938C2EC-5181-444D-88C9-631BF46BFCEEQ47979421-33E0C88A-3BBE-4443-A5E6-5023E66843A6Q49678698-5B8803B3-5F9B-451A-B319-3F7EE2941853Q49784365-EEAD0352-DD01-4A92-8D6C-8528E5E6AF83Q50089791-98E5896F-7055-4FFF-A8D7-ABBF9BD5C233Q51436755-209E56F0-2E40-4E61-8E54-599F89BAE058Q57135103-D1491CC0-39C2-401D-B314-A272226692B6Q58778223-DF0A38D1-FAF2-40DA-8E09-AED801EA7076
P2860
Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Genome-Wide Association Studie ...... hy in ECOG-5103 and ECOG-1199.
@ast
Genome-Wide Association Studie ...... hy in ECOG-5103 and ECOG-1199.
@en
type
label
Genome-Wide Association Studie ...... hy in ECOG-5103 and ECOG-1199.
@ast
Genome-Wide Association Studie ...... hy in ECOG-5103 and ECOG-1199.
@en
prefLabel
Genome-Wide Association Studie ...... hy in ECOG-5103 and ECOG-1199.
@ast
Genome-Wide Association Studie ...... hy in ECOG-5103 and ECOG-1199.
@en
P2093
P2860
P50
P1476
Genome-Wide Association Studie ...... hy in ECOG-5103 and ECOG-1199.
@en
P2093
Ann Partridge
Anne O'Neill
Bryan P Schneider
Carol White
Daniel Koller
Dongbing Lai
Elda Railey
Fengmin Zhao
George W Sledge
P2860
P304
P356
10.1158/1078-0432.CCR-15-0586
P407
P577
2015-07-02T00:00:00Z